AARF Act of 2021
Latest action · Mar 17, 2021 Referred to the Subcommittee on Health.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedMar 16, 2021
- Passed HouseNot reached
- Passed SenateNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
Animals for Regulatory Fairness Act of 2021 or the AARF Act of 2021
This bill requires the Food and Drug Administration to allow an applicant for approval to market a new drug to use a non-animal test to demonstrate the safety and effectiveness of the drug if the non-animal test satisfies all other applicable requirements.
Cosponsors 25
Members who signed on, in the order they did. Signatures ran from Mar 16, 2021 to May 10, 2022; 3 are original cosponsors, there from the day it was introduced.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| D-FL | Alcee L. Hastings | Original | Mar 16, 2021 |
| R-PA | Brian K. Fitzpatrick | Original | Mar 16, 2021 |
| D-PA | Madeleine Dean | Original | Mar 16, 2021 |
| D-NJ | Jefferson Van Drew | Mar 17, 2021 | |
| R-FL | Matt Gaetz | Mar 17, 2021 | |
| D-MA | Ayanna Pressley | Mar 18, 2021 | |
| R-PA | Fred Keller | Mar 18, 2021 | |
| D-GA | Lucy McBath | Mar 18, 2021 | |
| D-MA | Stephen F. Lynch | Mar 18, 2021 | |
| D-OR | Earl Blumenauer | Apr 15, 2021 | |
| D-MI | Haley M. Stevens | Apr 15, 2021 | |
| R-FL | Maria Elvira Salazar | Apr 15, 2021 | |
| D-CA | Nanette Diaz Barragán | Apr 22, 2021 | |
| D-PA | Matt Cartwright | May 11, 2021 | |
| D-PA | Mary Gay Scanlon | May 13, 2021 | |
| D-NH | Ann M. Kuster | May 17, 2021 | |
| D-MA | Seth Moulton | Aug 13, 2021 | |
| D-IA | Cynthia Axne | Jan 11, 2022 | |
| D-CA | Judy Chu | Jan 11, 2022 | |
| D-IL | Marie Newman | Jan 11, 2022 | |
| D-IL | Mike Quigley | Jan 11, 2022 | |
| D-MA | Richard E. Neal | Jan 11, 2022 | |
| D-TN | Steve Cohen | Jan 11, 2022 | |
| D-NH | Chris Pappas | Jan 18, 2022 | |
| D-NJ | Tom Malinowski | May 10, 2022 |
Committees 1
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| House | Energy and Commerce Committee | Referred Mar 16, 2021 |
| Health Subcommittee | Referred Mar 17, 2021 |
Actions 3
Everything that happened, newest first.
- Mar 17, 2021Referred to the Subcommittee on Health.
- Mar 16, 2021Introduced in House
- Mar 16, 2021Referred to the House Committee on Energy and Commerce.
Research
What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.
Constitutional authority
The sponsor’s statement, as printed in the Congressional Record, vol. 167, no. 49, March 16, 2021, page H1413.
Related bills 1
Companion bills and other measures the record links to this one.
| Bill | Title | Relationship | Latest action |
|---|---|---|---|
| HR 8736 | AARF Act of 2020 | Reintroduction of | Nov 12, 2020 |
Titles 3
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- To amend the Federal Food, Drug, and Cosmetic Act to allow the sponsor of a drug to use a non-animal test as an alternative to an animal test for purposes of demonstrating the safety and effectiveness of a drug if such approach satisfies the requirements of the applicable statutes and regulations.
- Short Title(s) as Introduced
- Alternatives to Animals for Regulatory Fairness Act of 2021
- AARF Act of 2021
Subjects
Assigned by the Library of Congress. Policy area: Health.
Text 1
Each version as it was printed, newest first.
- Mar 16, 2021Introduced in House
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.
